This quality standard covers identifying and managing familial hypercholesterolaemia (FH) in children, young people and adults. FH is a type of high cholesterol that runs in families and increases the risk of heart disease. The quality standard describes high-quality care in priority areas for improvement.

It covers only heterozygous FH and not homozygous FH, which is rare and needs specialist care.

In November 2017, this quality standard was updated. The definitions and source guidance sections were amended to reflect the updated NICE guideline on familial hypercholesterolaemia: identification and management.

Keeping quality standards up to date

We checked and updated this quality standard in 2017. For further information, see update information.

Next review: August 2018

Quality standard development process

How we develop NICE quality standards